This is a preview of subscription content, log in via an institution to check access.
REFERENCES
R. K. Sharma, M. V. Doig, D. F. V. Lewis, and G. G. Gibson. Role of hepatic and renal cytochrome P-450 IVA1 in the metabolism of lipid substrates. Biochem.Pharmacol. 38:3621–3629 (1989).
T. Aoyama, J. P. Hardwick, S. Imaoka, Y. Funae, H. V. Gelboin, and F. J. Gonzalez. Clofibrate-inducible rat hepatic P450s IVA1 and IVA3 catalyze the omega-and (omega-1)-hydroxylation of fatty acids and the omega-hydroxylation of prostaglandins E1 and F2 alpha. J.Lipid Res. 31:1477–1482 (1990).
P. Su, K. M. Kaushal, and D. L. Kroetz. Inhibition of renal arachidonic acid omega-hydroxylase activity with ABT reduces blood pressure in the SHR. Am.J.Physiol. 275:R426-R438 (1998).
E. F. Johnson, C. N. Palmer, K. J. Griffin, and M. H. Hsu. Role of the peroxisome proliferator-activator receptor in cytochrome P450 4A gene regulation. FASEB J. 10:1241–1248 (1996).
R. C. Zangar, K. J. Woodcroft, and R. F. Novak. Differential effects of ciprofibrate on renal and hepatic cytochrome P450 2E1 expression. Toxicol.Appl.Pharmacol. 141:110–116 (1996).
M. B. Sewer, D. R. Koop, and E. T. Morgan. Differential inductive and suppressive effects of endotoxin and particulate irritants on hepatic and renal cytochrome P-450 expression. J.Pharmacol.Exp.Ther. 280:1445–1454 (1997).
M. B. Sewer, D. R. Koop, and E. T. Morgan. Endotoxemia in rats is associated with induction of the P4504A subfamily and suppression of several other forms of cytochrome P450. Drug Metab.Dispos. 24:401–407 (1996).
S. R. Mitchell, M. B. Sewer, S. S. Kardar, and E. T. Morgan. Characterization of CYP4A induction in rat liver by inflammatory stimuli: dependence on sex, strain, and inflammation-evoked hypophagia. Drug Metab.Dispos. 29:17–22 (2001).
T. B. Barclay, J. M. Peters, M. B. Sewer, L. Ferrari, F. J. Gonzalez, and E. T. Morgan. Modulation of cytochrome P-450 gene expression is tissue specific and peroxisome proliferatoractivated receptor-alpha dependent. J.Pharmacol.Exp.Ther. 290:1250–1257 (1999).
K. J. Tracey, B. Beutler, S. F. Lowry, J. Merryweather, S. Wolpe, I. W. Milsark, R. J. Hariri, T. J. Fahey III, A. Zentella, and J. D. Albert. Shock and tissue injury induced by recombinant human cachectin. Science 234:470–474 (1986).
K. Beier, A. Volkl, and H. D. Fahimi. TNF-alpha downregulates the peroxisome proliferator activated receptor-alpha and the mRNAs encoding peroxisomal proteins in rat liver. FEBS Lett. 412:385–387 (1997).
Y. L. Chen, I. Florentin, A. M. Batt, L. Ferrari, J. P. Giroud, and L. Chauvelot-Moachon. Effects of interleukin-6 on cytochrome P450-dependent mixed-function oxidases in the rat. Biochem.Pharmacol. 44:137–148 (1992).
L. Zheng, G. Fisher, R. E. Miller, J. Peschon, D. H. Lynch, and M. J. Lenardo. Induction of apoptosis in mature T cells by tumor necrosis factor. Nature 377:348–351 (1995).
A. J. Bruce, W. Boling, M. S. Kindy, J. Peschon, P. J. Kraemer, M. K. Carpenter, F. W. Holtsberg, and M. P. Mattson. Altered neuronal and microglial responses to excitotoxic and ischemic brain injury in mice lacking TNF receptors. Nat.Med. 2:788–794 (1996).
G. W. Warren, S. M. Poloyac, D. S. Gary, M. P. Mattson, and R. A. Blouin. Hepatic cytochrome P-450 expression in tumor necrosis factor-alpha receptor (p55/p75) knockout mice after endotoxin administration. J.Pharmacol.Exp.Ther. 288:945–950 (1999).
T. Omura and R. Sato. The carbon monoxide-binding pigment of liver microsomes. I. Evidence in hemoprotein nature. J.Biol.Chem. 239:2370–2378 (1964).
O. H. Lowry, N. J. Rosebrough, A. L. Farr, and R. J. Randall. Protein measurement with folin phenol reagent. J.Biol.Chem. 193:265–275 (1951).
M. Hiratsuka, T. Matsuura, E. Watanabe, M. Sato, and Y. Suzuki. Sex differences in constitutive level of renal lauric acid hydroxylase activities and CYP4A-related proteins in mice. Biol.Pharm.Bull. 19:512–517 (1996).
D. D. Giera and R. B. van Lier. A convenient method for the determination of hepatic lauric acid omega-oxidation based on solvent partition. Fundam.Appl.Toxicol. 16:348–355 (1991).
M. C. Romano, K. M. Straub, L. P. E. R. D. Yodis, and J. F. Newton. Determination of microsomal lauric acid hydroxylase activity by HPLC with flow-through radiochemical quantitation. Annal.Biochem. 170:83–93 (1988).
R. F. Beers and I. W. Sizer. A spectrophotometric method for measuring the breakdown of hydrogen peroxide by catalase. J.Biol.Chem. 195:133–136 (1952).
J. H. Parmentier, H. Schohn, M. Bronner, L. Ferrari, A. M. Batt, M. Dauca, and P. Kremers. Regulation of CYP4A1 and peroxisome proliferator-activated receptor alpha expression by interleukin-1beta, interleukin-6, and dexamethasone in cultured fetal rat hepatocytes. Biochem.Pharmacol. 54:889–898 (1997).
J. H. Parmentier, P. Kremers, L. Ferrari, A. M. Batt, J. E. Gielen, and G. Siest. Repression of cytochrome P450 by cytokines: IL-1 beta counteracts clofibric acid induction of CYP4A in cultured fetal rat hepatocytes. Cell Biol.Toxicol. 9:307–313 (1993).
C. Rodriguez, V. Noe, A. Cabrero, C. J. Ciudad, and J. C. Laguna. Differences in the formation of PPARalpha-RXR/ acoPPRE complexes between responsive and nonresponsive species upon fibrate administration. Mol.Pharmacol. 58:185–193 (2000).
A. V. Yeldandi, M. S. Rao, and J. K. Reddy. Hydrogen peroxide generation in peroxisome proliferator-induced oncogenesis. Mutat.Res. 448:159–177 (2000).
S. C. Hasmall, N. H. James, N. Macdonald, F. J. Gonzalez, J. M. Peters, and R. A. Roberts. Suppression of mouse hepatocyte apoptosis by peroxisome proliferators: role of PPARalpha and TNFalpha. Mutat.Res. 448:193–200 (2000).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Van Ess, P.J., Poloyac, S., Mattson, M.P. et al. Blunted Induction of Hepatic CYP4A in TNF (p55-/-/p75-/-) Double Receptor Knockout Mice Following Clofibrate Treatment. Pharm Res 19, 709–713 (2002). https://doi.org/10.1023/A:1015326717522
Issue Date:
DOI: https://doi.org/10.1023/A:1015326717522